This asset is immune the COVID-19 and it could be heading much higher. Here’s why.
Read MoreThese 3 stocks look like solid buys now according to one expert. Here’s why.
Read MoreThese 3 stocks have taken a beating, and two analysts say now’s the time to buy them.
Read MoreThe market rout is creating attractive buying opportunities for these 10 stocks.
Read MoreTrade Setup Buy Target $3.91 Sell Target $4.57 Teekay Corporation provides crude oil and gas marine transportation; offshore oil production; and storage and offloading services in Bermuda and internationally. It operates shuttle tankers; floating production, storage, and offloading units; floating storage and offloading units; HiLoad dynamic positioning units; long-distance towing and offshore installation vessels; and […]
Read MoreTrade Setup Buy Target $17.21 Sell Target $20.47 Teekay Tankers Ltd. provides marine transportation services to oil industries in Bermuda and internationally. It operates through two segments, Conventional Tanker and Ship-to-ship Transfer (STS). The company offers voyage and time charter services; and offshore STS transfer services of commodities primarily crude oil and refined oil products, […]
Read MoreThis week, the market continues to be volatile, but uncertain. Coronavirus, Super Tuesday, geopolitics, trade, interest rate policy – it seems like everything is getting added to the mix right now. Increasing uncertainty is a good reason to start looking for generally more conservative ways to put your money to work for you. That means […]
Read MorePlus, activity in the U.S. services sector accelerated in February, GE said the coronavirus will impact Q1 earnings, and Arcturus Therapeutics shares are on the rise after the company joins the quest to find a COVID-19 vaccine.
Read MoreBuy Target – $21.00 or better Sell Target – TradersPro Sell Signal Cue Biopharma, Inc., a biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate CUE-101, a protein biologic designed to target and activate […]
Read More